4//SEC Filing
SCHAEFFER LEONARD D 4
Accession 0000899243-17-029322
CIK 0001604950other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 4:18 PM ET
Size
8.0 KB
Accession
0000899243-17-029322
Insider Transaction Report
Form 4
SCHAEFFER LEONARD D
Director
Transactions
- Exercise/Conversion
Common Stock
2017-12-19$1.66/sh+22,631$37,567→ 57,449 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-12-19−22,631→ 5,223 totalExercise: $1.66Exp: 2024-09-17→ Common Stock (22,631 underlying)
Holdings
- 43,104(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of all of the reported shares for purposes of Section 16 or any other purpose.
- [F2]25% of the shares vested on September 17, 2015, and an additional 1/48th vests on the last day of each one month period thereafter.
Documents
Issuer
scPharmaceuticals Inc.
CIK 0001604950
Entity typeother
Related Parties
1- filerCIK 0001016369
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 4:18 PM ET
- Size
- 8.0 KB